Latest news & insights
Boyds is now a proud member of MassBio
As part of our continued growth plans in the US, Boyds is delighted to join MassBio as a proud member.
Boyds shortlisted for BioNow Business Support Award
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
Boyds joins Texas Healthcare and Bioscience Institute (THBI) as proud member
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
Boyds collaborates with BioPharma Connections
Boyds partners with BioPharma Connections in the company’s latest move to continue its growth in the U.S.
Double win for Boyds at TOPRA Awards 2023
The TOPRA Awards 2023 saw the Boyds team take home two awards, with our regulatory affairs team crowned winners of the Futures Award and our
Boyds grows regulatory affairs team with new hire
We are delighted to announce the appointment of Monica Pianella as Associate Director of Regulatory Affairs. With over seven years’ experience in advanced therapies, Monica
Boyds launches ‘Conversations in Drug Development’ podcast
Boyds has announced the launch of a brand-new podcast series that aims to keep the scientific and clinical community abreast of the latest advancements in cell and gene therapy and drug development.
Chris Moore discusses key considerations for US biotechs setting up gene therapy studies in Europe
In the viewpoint article: ‘Key considerations for US biotechs setting up gene therapy studies in the UK and Europe’, Chris highlights some of the important things organisations must consider before initiating their study.
